Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 5.3.99.5 extracted from

  • Murakami, S.; Nagaya, N.; Itoh, T.; Kataoka, M.; Iwase, T.; Horio, T.; Miyahara, Y.; Sakai, Y.; Kangawa, K.; Kimura, H.
    Prostacyclin agonist with thromboxane synthase inhibitory activity (ONO-1301) attenuates bleomycin-induced pulmonary fibrosis in mice (2006), Am. J. Physiol., 290, L59-L65.
    View publication on PubMed

Application

Application Comment Organism
medicine in addition to inhibitory activity, application of ONO-1301, i.e. ([5-[2-([[(1E)-phenyl(pyridin-3-yl)methylidene]amino]oxy)ethyl]-7,8-dihydronaphthalen-1-yl]oxy)acetic acid, significantly attenuates the development of pulmonary fibrosis and improves survival after treatment with bleomycin Mus musculus

Inhibitors

Inhibitors Comment Organism Structure
([5-[2-([[(1E)-phenyl(pyridin-3-yl)methylidene]amino]oxy)ethyl]-7,8-dihydronaphthalen-1-yl]oxy)acetic acid i.e. ONO-1301, in addition to inhibitory activity, application of ONO-1301 significantly attenuates the development of pulmonary fibrosis and improves survival after treatment with bleomycin Mus musculus

Organism

Organism UniProt Comment Textmining
Mus musculus
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining